Advertisement
UK markets close in 24 minutes

  • FTSE 100

    8,137.89
    +59.03 (+0.73%)
     

  • FTSE 250

    19,819.92
    +217.94 (+1.11%)
     

  • AIM

    755.35
    +2.23 (+0.30%)
     

  • GBP/EUR

    1.1667
    +0.0010 (+0.09%)
     

  • GBP/USD

    1.2466
    -0.0045 (-0.36%)
     

  • Bitcoin GBP

    51,325.64
    +458.72 (+0.90%)
     

  • CMC Crypto 200

    1,331.17
    -65.37 (-4.68%)
     

  • S&P 500

    5,106.75
    +58.33 (+1.16%)
     

  • DOW

    38,225.57
    +139.77 (+0.37%)
     

  • CRUDE OIL

    83.48
    -0.09 (-0.11%)
     

  • GOLD FUTURES

    2,343.60
    +1.10 (+0.05%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,162.90
    +245.62 (+1.37%)
     

  • CAC 40

    8,097.80
    +81.15 (+1.01%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Why These Two Biotech Stocks Blasted Higher This Week

Eric Volkman, The Motley Fool
·2-min read
Why These Two Biotech Stocks Blasted Higher This Week

Two somewhat under-the-radar biotech companies saw their share prices soar this week after agreeing to be acquired. CinCor Pharma (NASDAQ: CINC) is being bought out by deep-pocketed pharmaceutical company AstraZeneca, while Albireo Pharma (NASDAQ: ALBO) is set to be owned by France-based peer Ipsen. Both of these deals are very lucrative, to the point where CinCor's stock rocketed 146% over the course of the week, and Albireo shot 92% skyward, according to data compiled by S&P Global Market Intelligence.

Continue reading